Search

On Tuesday morning I suggested traders might want to take some profits in positions accumulated the week before, because of a possible dearth of catalysts on the near-term horizon. I also suggested maintaining long-term exposure to the group.

WHAT TO DO NOW: The market’s selloff this week is accelerating today, once again led by growth stocks. The Nasdaq is fully in re-test mode at this point, and while many stocks are showing some relative strength overall, we remain cautious given the selling with our growth-heavy indicators (Growth Tides, Aggression Index) looking poor. We sold TransMedics (TMDX) in last night’s issue, and today we’re going to cut bait with ProShares Russell 2000 Fund (UWM), which will leave us with around 49% in cash.

Today, a whopping eight Profit Booster positions will expire. Most are “slam-dunk,” full-profit trades, while others will go down to the wire.

The big takeaway, before we dive in, is we are going to let the situation play itself out, and come Monday/Tuesday of next week we will revisit our profits, as well as how we will manage the remaining positions.

WHAT TO DO NOW: The market’s rally has run into trouble, and while there are more than a few growth stocks that look fine (if not great), air pockets are reappearing in many issues. Today, Nutanix (NTNX), which looked picture-perfect heading into its earnings report, is getting mauled along with most other software stocks. We’re going to sell the rest of our stake today, thinking today’s meltdown after a prolonged run isn’t likely to lead to good things in the intermediate term. We’ll have more details (and likely other changes) in tonight’s issue of Cabot Growth Investor.

Today, a whopping eight Profit Booster positions will expire. Most are “slam-dunk,” full-profit trades, while others will go down to the wire.

The big takeaway, before we dive in, is we are going to let the situation play itself out, and come Monday/Tuesday of next week we will revisit our profits, as well as how we will manage the remaining positions.

As I do from time to time around the major holidays, I spent much of the weekend hanging with family and traveling. That means this week’s Monday Week in Review will be focused on our open positions.

Of note, I am working the full week, outside of Thursday, when the market will be closed for New Year’s.

As I do from time to time around the major holidays, I spent much of the weekend hanging with family and traveling. That means this week’s Monday Week in Review will be focused on our open positions.

Of note, I am working the full week, outside of Thursday, when the market will be closed for New Year’s.

WHAT TO DO NOW: The market remains very mixed, as we continue to see some tempting names but also more than a few that are hitting potholes, as well as rotation into safe areas. Yesterday, we sold Life360 (LIF) after that stock fell apart on earnings—and now we’re going to sell our half-sized stake in AppLovin (APP), with Friday’s and Monday’s encouraging action going up in smoke since. That will leave us with a high-50% cash position, which is a lot; if the market stabilizes, we’ll probably start a couple of new positions, but for the moment we’ll sit with that cash and see how things play out.

WHAT TO DO NOW: The market has finally seen some selling this week, with two downside reversals and then today’s big drop on tariff and economic fears. Our Cabot Tides are now on the fence as the broad indexes have sagged, though with 30% cash already on the sideline, we’re taking things on a stock-by-stock basis. Today that means pulling the plug on Snowflake (SNOW), which is cracking support today. This will raise our cash level to 39%—some of which we might redeploy into a stronger name when the indexes find support. Details below.

WHAT TO DO NOW: The market tried to stabilize earlier this week, but today’s action is ugly and is hitting many areas; our Cabot Tides have turned down, joining most growth stock measures. The Model Portfolio is already nearly two-thirds in cash, but today we’ll add to that, cutting loose Axsome Therapeutics (AXSM), which is following through to the downside after its post-earnings dip. That will leave us with a high-60% cash position; we’ll have more details (and possibly more changes) in tonight’s update.

WHAT TO DO NOW: The indexes continue to look good, and the big-picture (months down the road) outlook is very favorable. But growth stocks remain hit and miss, with some newer names perking up but many potholes out there, too. Today, we’re going to sell one-third of our stake in GE Aerospace (GE), which has been a fine performer, but it’s been lagging a bit, got hit today and many in the group have topped. We’ll take a few chips off the table and hold the rest, leaving us with around 42% in cash.

Here are some portfolio notes, for those of you who like to assess your stocks over the weekend. Energy stocks are having what appear to be normal pullbacks. Take advantage of the lower prices, and buy BP plc (BP), ExxonMobil (XOM), Total (TOT) and Tesoro (TSO).

In the June Issue of Cabot Early Opportunities we talk Artificial Intelligence (AI) and break down the technology into a few buckets of opportunity that make it a little easier to understand.

I also profile five ways investors can put their money to work in companies with AI exposure.

Enjoy!

Three stocks move from Strong Buy to Hold, and two stocks are good buys here.